Patent · US Active

2,5-substituted oxazolopyrimidine derivatives

US9040544B2 · kind B2 · utility

1Cited by

1References

13Claims

0Family size

Assignee

Sanofi · FR

Inventors

Dieter Kadereit · Kelkheim, DE
Matthias Schaefer · Frankfurt am Main, DE
Stephanie Hachtel · Frankfurt am Main, DE
Axel Dietrich · Frankfurt am Main, DE
Thomas Huebschle · Frankfurt am Main, DE
Katrin Hiss · Frankfurt am Main, DE

Key dates

Filing date	Jan 14, 2011
Grant date	May 26, 2015
Priority date	—
Expiry date	Mar 22, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D498/22
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to oxazolopyrimidine compounds of formula I, where A, R1 and R2 are defined as stated in the claims. The compounds of formula I are suitable, for example, for wound healing.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.